← Back to all signals
RESEARCH PAPER ANALYSIS

What Is the Relationship Between Clinician-reported and Patient-reported Outcomes in Orthopaedic Surgery?

AI interpretation is pending for this paper.

Open original publication →
PMID42190173
JournalClinical orthopaedics and related research
Publication Date2026-05-26
Ingested2026-08-02 12:06 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Patient-reported outcome measures (PROMs) and clinician-reported outcome measures (CROMs) are designed to capture different dimensions of treatment response: the patient's experience and the clinician's assessment, respectively. Because of that, some degree of discordance between them is expected. However, the nature and magnitude of PROM-CROM correlations across orthopaedic subspecialties have not been systematically characterized. Understanding where they converge and where they diverge may help clinicians and researchers select instrument pairings that capture complementary dimensions of treatment response for different musculoskeletal conditions. QUESTIONS/PURPOSES: (1) Do CROMs correlate differently with condition-specific PROMs compared with general health PROMs? (2) Do PROMs show distinct correlations with hard CROMs (objective, performance-based measures without patient-reported outcomes) versus soft CROMs (objective, performance-based measures including patient-reported domains)? (3) How do PROMs and CROMs compare in their ability to detect change over time as measured by responsiveness indices such as effect size, standardized response mean, and other related metrics? METHODS: We systematically searched Medline via PubMed, Embase, and Web of Science Core Collection in July 2025. Two reviewers independently performed title, abstract, and full-text screening. Studies were included when they directly compared PROMs and CROMs for orthopaedic-related topics. Extracted variables included study design, sample size, Spearman and Pearson correlation coefficients, and responsiveness. CROMs were classified as "hard" or "soft" based on the extent to which the instrument relied on patient input. Hard CROMs represent objective, performance-based or clinician-measured outcomes that do not require patient-reported information, whereas soft CROMs include clinician-administered instruments that incorporate patient-reported symptoms or functional assessments. PROMs were categorized as either generic or condition specific (joint-, region-, disease-specific) according to established definitions. All reported correlation coefficients were extracted and included regardless of statistical significance to comprehensively characterize the magnitude and variability of associations between PROMs and CROMs. Responsiveness was defined as the comparative sensitivity of PROMs and CROMs to clinical change, assessed using effect sizes, standardized response means, and related metrics. Thirty studies met inclusion criteria; 27 reported PROM-CROM correlations and nine evaluated responsiveness. The included studies encompassed a variety of musculoskeletal conditions, including musculoskeletal tumors (n = 4), distal radius fractures (n = 3), total joint arthroplasty and osteoarthritis (n = 11), pediatric limb deformities (n = 3), foot and ankle disorders (n = 7), spine (n = 1), and trauma (n = 1), with sample sizes ranging from 20 to 717 (mean = 143). Assessment of study quality, using an adapted Consensus-based Standards for the Selection of Health Measurement Instruments risk of bias framework, revealed that most studies were of "low risk" or "some concerns" because of incomplete paired PROM-CROM outcome data rather than flaws in design or analysis. RESULTS: In evaluating relationships between PROMs and CROMs across orthopaedic subspecialties, condition-specific PROMs generally showed stronger correlations with corresponding CROMs, including the Toronto Extremity Salvage Score (r = 0.75 to 0.81) and the patient-reported American Orthopaedic Foot & Ankle Society (AOFAS) score (r = 0.70). In contrast, general health measures such as the EQ-5D time trade-off (r = -0.29 to 0.13) and certain region-specific instruments, including the Oswestry Disability Index (r = 0.27) and several upper extremity PROMs (r = -0.046 to 0.41), often demonstrated weaker correlations with CROMs. When evaluating differences in correlation by CROM subtype, PROMs tended to correlate more strongly with soft CROMs, such as the AOFAS score, Musculoskeletal Tumor Society score, and Harris hip score, than with hard CROMs. In comparing responsiveness between PROMs and CROMs, condition-specific PROMs, including the Manchester-Oxford Foot Questionnaire, the WOMAC, and Knee Society Score, were more often sensitive to clinical change than CROMs, except in rehabilitation-focused settings, where hard CROM responsiveness was often greater than for PROMs and soft CROMs. CONCLUSION: Based on currently available studies related to musculoskeletal conditions, PROMs and CROMs show variable associations with one another. The stronger correlations between soft CROMs and condition-specific PROMs suggest that when the goal is to establish benchmarks, a condition-specific PROM should be paired with a soft CROM. In contrast, hard CROMs may be particularly useful in short-term rehabilitation settings, where objective performance changes are a primary focus of evaluation. We recommend that orthopaedic studies and registries include, at a minimum, one condition-specific PROM (or soft CROM) and one hard CROM to ensure a multidimensional assessment of patient outcomes and improve interpretability across studies. LEVEL OF EVIDENCE: Level III, therapeutic study.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 The Lipid Switch: Ultra-High Dose Omega Fatty Acids Determine MYCN Neuroblastoma Fate and Implicate Substrate-Level Oxylipin Competition. ACS pharmacology & translational science 56.12 2 Managing skin-related adverse events during mirdametinib treatment for NF1-PNs: expert guidance from the ReNeu trial. Frontiers in oncology 80.36 3 CAR T cell-induced interferon gamma enhances MHC class I expression and sensitizes neuroblastoma to TCR-engineered T cell therapy. Frontiers in immunology 51.92 4 Pediatric Spinal Cord Astrocytoma With Granular Cell-Like Morphology and KIAA1549::BRAF Fusion. Neuropathology : official journal of the Japanese Society of Neuropathology 56.4 5 Can O-RADS Be Validated in Children Using a Malignant-Only Cohort? Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 47.5 6 Continuous infusion of granulocyte colony-stimulating factor is associated with an advantage in neutrophil recovery in pediatric oncologic disorders. Cancer chemotherapy and pharmacology 64.3 7 Fertility-related knowledge and childbearing attitudes among female survivors of hematopoietic stem cell transplantation: a cross-sectional study. Journal of cancer survivorship : research and practice 61.1 8 Fibrolamellar Carcinoma in the Molecular Era: From DNAJB1::PRKACA Biology to Precision Therapeutic Strategies. Journal of gastrointestinal cancer 86.04 9 Focal periphyseal edema with atypical MRI features: Biopsy findings and imaging follow-up. Radiology case reports 56.0 10 CyberKnife SBRT plus lenvatinib and tislelizumab versus doublet systemic therapy for hepatocellular carcinoma with macrovascular invasion: A real-world IPTW-adjusted study. Clinical and translational radiation oncology 83.24 11 Single-session therapeutic plasma exchange as salvage therapy for pegaspargase-induced severe acute pancreatitis accompanied by multiple organ dysfunction in a pediatric patient with B-cell precursor acute lymphoblastic leukemia: a case report. BMC pediatrics 67.0 12 Evaluation of Regulatory B10 Cells in Common Variable Immunodeficiency Patients with and without Autoimmunity. Iranian journal of allergy, asthma, and immunology 59.1 13 An Unexpected Association of a Novel MYOF Variant with Generalized Myopathy and HAE-nl-C1-INH. Iranian journal of allergy, asthma, and immunology 38.6 14 Case Report: CBFA2T3::GLIS2-positive myeloid sarcoma with focal bone marrow involvement mimicking Ewing sarcoma in an infant. Frontiers in oncology 56.6 15 Extended genotype-phenotype spectrum of 17α-hydroxylase/17,20-lyase deficiency: a nine-case series featuring a novel mutation, suspected TART-like lesions, and multisystem involvement. Frontiers in endocrinology 54.5 16 Reninoma in an adolescent boy with negative selective renal vein sampling: a case report and review of the literature. Frontiers in endocrinology 50.3 17 Precision-based exercise protocols for children with cancer: a methodological approach from the European FORTEe research project. Frontiers in pediatrics 76.6 18 CircHIPK3 promotes the progression of B-cell acute lymphoblastic leukemia in children by binding to STAT3. Frontiers in pharmacology 54.3 19 Disease-specific heterogeneity of C-reactive protein across 21 hematologic disorders reflects divergent inflammatory and hematopoietic phenotypes. Frontiers in immunology 76.0 20 Exercise intervention for children with acute leukemia: a best evidence summary. Frontiers in pediatrics 82.2 21 Oral and maxillofacial malignancies in children and adolescents: a 17-year single-center retrospective study. World journal of pediatric surgery 66.9 22 Adult Recurrent Wilms' Tumor Presenting as a Large Mass: A Case Report and Current Literature Review. Sisli Etfal Hastanesi tip bulteni 56.7 23 Exploring beyond the typical Wilms tumor: What a radiologist needs to know. Current problems in diagnostic radiology 60.4 24 The association between the oral microbiome and oral Kaposi's sarcoma-associated herpesvirus (KSHV) shedding is modified by age and HIV status in a rural Ugandan cohort. Journal of oral microbiology 58.0 25 Diagnostic Accuracy and Predictive Factors of Sentinel Lymph Node Biopsy in Cutaneous Squamous Cell Carcinoma: A Systematic Review. Plastic surgery (Oakville, Ont.) 74.5 26 Expanding the Molecular Data of DICER1-Related Tumor Predisposition: Novel Germline Variants in an Argentine Pediatric Cohort. Human mutation 58.0 27 Epidemiology and neurological profiling of vertebral tumors in Mexico: a five-year review from a tertiary referral center. Spinal cord series and cases 63.0 28 A comparison of a novel neuropsychological screening tool with provider recommendations among pediatric cancer survivors. Journal of cancer survivorship : research and practice 61.5 29 Environmental Asbestos Exposure as a Possible Pathway to Early-Onset Pleural Mesothelioma: A Case From Afghanistan and Pakistan to London. Respirology case reports 45.5 30 Clinical consensus guidelines for the management of Noonan syndrome in Japan. Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology 74.6 31 Radioiodine or thyroidectomy in children and adolescents with Graves' disease: a structured literature review of efficacy and safety. Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology 74.6 32 Genomic characterization of carbapenem-resistant organisms from pediatric patients with hematological malignancies and genomic comparison of infection versus intestinal colonizing strains. Microbiology spectrum 62.9
PATIENT-FRIENDLY SUMMARY

What Is the Relationship Between Clinician-reported and Patient-reported Outcomes in Orthopaedic Surgery?

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic